Orexin 2R NAM program (Addex)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOrexin 2R NAM program (Addex)
Drug Alias NameOrexin type 2 receptor negative allosteric modulators (Addex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 antagonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A